Search Resources
Search Results
The Centers for Disease Control and Prevention (CDC) published a new report, Illicitly Manufactured Fentanyl-Involved Overdose Deaths with Detected Xylazine which highlights the presence of xylazine, a non-opioid tranquilizer not … read more
This issue brief provides an overview of published statewide opioid settlement spending plans and appropriations made to date and highlights initial priorities and investments outlined in these plans.
This brief by the US Health and Human Services Office of Minority Health and the Office of the Assistant Secretary for Planning and Evaluation describes findings from a joint study … read more
This study compares substance use among Asian American adults in 2020, when anti-Asian violence increased, with substance use among the same group during the previous 4 years, and compare this … read more
This guide provides clinical practice-based information on the use of buprenorphine in the treatment of individuals using fentanyl and other highly potent synthetic opioids.
This article from The New York Times discusses results of a study of rates of prescribed addiction medicine for opioid use disorder by race. Findings indicate that black patients with … read more
These presentation slides summarize trends of xylazine in U.S. illicit drug supply, describe physiologic effects and manifestations of intoxication in persons using xylazine, and review risks of xylazine and harm … read more
Xylazine, a cutting agent making its way into the drug supply, increases risk of sedation, overdose, and wounds that are hard to heal. This guide focused on xylazine wounds and … read more
Use this resource developed by the New Hampshire Harm Reduction Coalition to learn more about sex work, including what it is, relevant policies and legislation, and how to promote safer … read more